Zygotic epigenetic reprogramming entails genome-wide DNA demethylation that is accompanied by Tet methylcytosine dioxygenase 3 (Tet3)-driven oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC; refs 1-4). Here we demonstrate using detailed immunofluorescence analysis and ultrasensitive LC-MS-based quantitative measurements that the initial loss of paternal 5mC does not require 5hmC formation. Small-molecule inhibition of Tet3 activity, as well as genetic ablation, impedes 5hmC accumulation in zygotes without affecting the early loss of paternal 5mC. Instead, 5hmC accumulation is dependent on the activity of zygotic Dnmt3a and Dnmt1, documenting a role for Tet3-driven hydroxylation in targeting de novo methylation activities present in the early embryo. Our data thus provide further insights into the dynamics of zygotic reprogramming, revealing an intricate interplay between DNA demethylation, de novo methylation and Tet3-driven hydroxylation.
In the mouse zygote, the paternal genome undergoes genomewide loss of DNA methylation shortly after fertilization 5, 6 . This has been mainly attributed to the activity of the Tet3 hydroxylase responsible for the accumulation of 5hmC on the paternal DNA (refs 1,3,4) . To elucidate the exact involvement of 5hmC during this DNA demethylation, we examined the detailed kinetics of 5hmC appearance in connection with loss of 5mC signal (Fig. 1a,b ). We confirmed accumulation of 5hmC in the paternal pronucleus at late zygotic stages [1] [2] [3] [4] , consistent with the described localization and expression pattern of the Tet3 enzyme ( Supplementary Fig. 1a,b ). Detailed analysis of 5mC and 5hmC immunofluorescence data, however, revealed that whereas 5mC disappears from the paternal genome by early PN3 stage, 5hmC starts to accumulate only after the main drop in 5mC has occurred, and increases considerably from PN4 onwards 7 (Fig. 1a-c) . Consequently, paternal DNA of late PN2-early PN3 zygotes shows neither 5mC nor 5hmC signal ( Fig. 1d) . Moreover, the accumulation of 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC; refs 8-10) is detectable concomitantly to 5hmC appearance in the paternal pronucleus, a few hours after the loss of 5mC ( Supplementary Fig. 1c ; ref. 10) . The delayed appearance of 5hmC is also not due to the low sensitivity of the 5hmC antibody, as 5hmC is detectable with considerably higher sensitivity than 5mC ( Supplementary Fig. 1d,e ).
Tet proteins belong to the family of 2-oxoglutarate (2OG) and iron (Fe 2+ )-dependent dioxygenases 11 . To assess the involvement of Tet3driven 5mC hydroxylation in zygotic demethylation, we eliminated 5hmC by using dimethyloxallyl glycine (DMOG), a small-molecule inhibitor of 2OG-dependent oxygenases. DMOG effectively blocks the activity of Tet enzymes in vitro ( Supplementary Fig. 2a ); consequently, the presence of DMOG during in vitro fertilization (IVF) leads to an absence of 5hmC, 5fC and 5caC in the paternal pronucleus ( Fig. 2a and Supplementary Fig. 2c,d ). Of note, DMOG treatment does not affect the presence of maternal 5hmC ( Fig. 2a ), the normal asymmetry of histone modifications observed between pronuclei ( Supplementary Fig. 3a ), or the development of preimplantation embryos ( Supplementary Fig. 2e,f) . Strikingly, the lack of 5hmC formation following DMOG treatment did not impact on the extent of DNA demethylation in early PN3 mouse zygotes ( Fig. 2a and Supplementary Fig. 2b ), which reinforced our initial observations showing that loss of paternal 5mC signal and accumulation of 5hmC are temporally disconnected. We further confirmed our findings by inhibiting Tet3 activity in the zygote using a Fe 2+ chelator, deferoxamin (DFX). This inhibitor also effectively blocks the formation of 5hmC, but has no impact on the loss of paternal 5mC signal in the early PN3 zygotes ( Supplementary Fig. 3b ,c), as also observed with DMOG. Collectively, these results suggest that the Tet3-driven accumulation of 5hmC observed in the late zygote is not required for the initial loss of paternal 5mC signal.
Line1 represents a class of non-LTR repetitive elements that has been shown to lose methylation during zygotic reprogramming 5, 12, 13 . Although these elements have been previously suggested as targets for 5mC hydroxylation in zygotes 2,3 , our results clearly show that Line1 elements (L1Md_Tf and L1Md_Gf subtypes) undergo DNA demethylation in the absence of 5hmC formation to a similar extent as that observed in the control zygotes and two-cell-stage embryos ( Supplementary Fig. 3d,e ).
Immunofluorescence analysis provides an indirect quantification of DNA modifications, relying on the specificity and the affinity of the antibodies used. Additionally, differences between staining protocols, signal acquisition and approaches used to normalize the resulting signal make direct comparison between studies problematic. Bisulphite analysis can provide sequence-specific information; however, the results are compromised by the inability to distinguish between 5mC and 5hmC and between C, 5fC and 5caC (refs 8,9,14) . In addition, whole-genome bisulphite analysis is subject to amplification biases and the lack of information regarding the Supplementary Fig. 4e ). Limits of quantification are summarized in Supplementary Fig. 4a . For peaks below the quantification limit, an overestimation of the 5hmC/dG ratio is calculated based on the limit of detection of 5hmC. (c) Quantification of DNA modifications in two-cell embryos derived from DMOG-treated or control zygotes analysed by LC-MS (n = 2 independent experiments and two technical replicates for each point copy number of various repetitive elements in the genome precludes precise quantitative assessment of the dynamic changes in global DNA modifications. Considering these facts we further supported our findings by an independent quantitative approach using an ultrasensitive liquid chromatography-mass spectrometry (LC-MS) method ( Supplementary Fig. 4a ). Quantitative assessment of 5mC levels in normal fertilized zygotes (PN4-5) by LC-MS showed a clear 5mC loss in comparison with 5mC values measured in either of the gametes ( Fig. 2b and Supplementary  Fig. 4e ) providing additional evidence for zygotic DNA demethylation. To assess the relative contribution of parental genomes to the measured 5mC levels, we quantified 5mC in parthenogenetically activated oocytes that lack the contribution of a sperm-derived genome. Our LC-MS measurements show that parthenotes contain a quantitatively similar amount of 5mC to MII oocytes (P = 0.075, t-test; Supplementary Fig. 4c ). The global level of DNA methylation is also not significantly affected by DNA replication as shown by 5mC levels in parthenotes treated with aphidicolin (P = 0.078, t-test; Supplementary Fig. 4b,c ). As the maternal methylation remains globally stable ( Supplementary Fig. 4c ), the measured 5mC quantity in zygotes implies that the paternal genome at PN4-5 (10 h postfertilization) has lost~70% of 5mC compared with the sperm ( Supplementary Fig. 4d ). We confirmed that this measured loss of global 5mC occurs independently of the completion of S phase (P = 0.058 between control and aphidicolin-treated zygotes, t-test; Supplementary Fig. 4f -h). Although we cannot preclude that demethylation of some loci requires S-phase progression 15, 16 , our quantitative measurements demonstrate that on a genome-wide level the zygotic DNA demethylation is predominantly an active, replication-independent process 5, 17, 18 ( Supplementary Fig. 4f -h).
Our LC-MS data further show that the absolute 5hmC level in zygotes is very low compared with the amount of paternal 5mC lost during this wave of DNA demethylation ( Fig. 2b and Supplementary  Fig. 4e ). Importantly and confirming our immunofluorescence data ( Fig. 2a and Supplementary Fig. 2b ), the measured global loss of 5mC is not affected by the absence of 5hmC in the DMOG-treated zygotes. These results thus demonstrate that 5hmC is not required for removal of most 5mC in the early PN3 zygotes ( Fig. 2a,b and Supplementary Fig. 4e ).
To provide further genetic validation of our results, we generated a conditional oocyte-specific Tet3 knockout (KO) mouse model ( Fig. 3a ). Gdf9-Cre-driven Tet3 deletion in early oocytes resulted in a complete absence of Tet3 messenger RNA in Tet3 mat-MII oocytes (P < 0.001, t-test, Fig. 3b ) and Tet3 protein in zygotes ( Fig. 3c ). This results in a lack of 5hmC formation in the paternal pronucleus following fertilization as assessed by immunofluorescence and by LC-MS of zygotes 3 (Fig. 3d,e ). In agreement with our data using dioxygenase inhibitors ( Fig. 2a,b and Supplementary Fig. 3c ), ablation of maternal Tet3 did not affect early loss of paternal 5mC observed in PN3 zygotes by immunofluorescence ( Fig. 3d and Supplementary Fig. 4i ) nor global 5mC levels in Tet3 mat-/pat+ zygotes as measured by LC-MS ( Fig. 3e ). Combined, these results thus do not corroborate the accepted model whereby 5hmC is an intermediate for global DNA demethylation that occurs in early pre-replicative (PN3) mouse zygotes [1] [2] [3] [4] .
Further assessment of DMOG-treated and Tet3 mat-/pat+ zygotes revealed that whereas the initial DNA demethylation proceeded normally in the absence of 5hmC formation, a slight accumulation of 5mC was detectable by immunofluorescence in the paternal pronucleus of later (late PN4-PN5) stage zygotes (Figs 2a and 3d and Supplementary Figs 2b and 4i ). Although our LC-MS measurements did not detect any significant difference in 5mC in either Tet3 mat-/pat+ or DMOG-treated zygotes, most likely owing to pooling of slightly different stages of zygotes (Figs 2b and 3e and Supplementary  Fig. 4e ), loss of 5hmC in the zygote leads to a detectable, albeit small, increase in 5mC in the two-cell-stage embryos derived from DMOG-treated (P < 0.001, t-test, Fig. 2c ) and Tet3 mat-/pat+ zygotes (P < 0.05, t-test, Fig. 3f ). The observed limited accumulation of 5mC in late-stage Tet3-KO and DMOG-treated zygotes is in agreement with the previously described contribution of Tet3 to zygotic DNA demethylation 1, 3, 4 . However, and contrary to previous interpretation, our data document that the accumulation of 5mC occurs only once the initial wave of DNA demethylation has been completed (Figs 1c, 2a and 3d and Supplementary Figs 2b and 4i ).
The accumulation of 5mC in the paternal pronucleus of latestage DMOG-treated or Tet3-depleted zygotes indicates the presence of de novo methylation activity. However, the current models of zygotic epigenetic reprogramming assume the lack of 5mC maintenance during replication in the mouse preimplantation embryos 13, 19 . Additionally, given the general loss of DNA methylation during zygotic and early preimplantation development 5, 6, 13, 17 , the role or even existence of de novo DNA methylation in the early embryos has not been previously considered. To revise this assumption, we investigated the presence of maintenance and de novo DNA methylation activities in the zygotes using isotope labelling. The addition of isotope-labelled methionine during the IVF procedure resulted in a clear incorporation of labelled 5mC (5mC * ) detectable in late-stage (PN4-5) zygotes ( Fig. 4a ). This signal is reduced, but still clearly detectable, following treatment with aphidicolin ( Fig. 4a ), unambiguously demonstrating that both the maintenance (replication coupled) and de novo (replication independent) methylation activities are present in the mouse zygote.
This prompted us to consider whether the late appearance of 5hmC in paternal pronuclei could be mechanistically linked to the zygotic DNA methylation activity rather than to the sperm-derived 5mC as proposed in the current models 1, 3, 4 . We carried out IVF in the presence of 5-azadeoxycytidine (azadC), an inhibitor of DNA methyltransferases that requires incorporation into DNA during replication. Zygotes incubated with azadC show a significant decrease in 5hmC level in the paternal pronucleus ( Fig. 4b ), demonstrating that 5hmC accumulation is linked to the generation of new zygotic 5mC. Notably, no significant difference in paternal 5mC is observed in azadC-treated zygotes, either by immunofluorescence or by bisulphite sequencing of Line1 elements ( Supplementary Fig. 4j ). This suggests that following the zygotic S phase the observed de novo DNA methylation is limited and most newly deposited 5mC is converted to 5hmC on the paternal genome. This conclusion is in agreement with the low absolute levels of 5hmC measured by LC-MS ( Fig. 2b ).
Previous reports have demonstrated the role of Dnmt3a and Dnmt3L in de novo DNA methylation during oocyte growth [20] [21] [22] [23] [24] . In early mouse zygotes both Dnmt3a and Dnmt3L show pronuclear localization with progressive enrichment until PN5 ( Supplementary  Fig. 5a ; refs 25,26) . To address whether Dnmt3a/3L-driven de novo DNA methylation could provide a template for 5hmC formation during zygotic development, we assessed 5hmC levels in zygotes maternally depleted for Dnmt3a (Dnmt3a 2lox/2lox , Zp3-Cre) and Dnmt3L (Dnmt3L −/− ). Consistent with previous reports, the lack of maternally inherited Dnmt3a and Dnmt3L results in loss of DNA methylation in the maternal genome 20,24,27,28 ( Fig. 4c and Supplementary Fig. 5b ). Additionally, the loss of maternal Dnmt3a, but not Dnmt3L ( Fig. 4c and Supplementary Fig. 5b ), leads to significantly reduced paternal 5hmC in PN4 zygotes. We thus conclude that Dnmt3a-driven de novo DNA methylation is required for 5hmC formation in late zygotes.
Paternal accumulation of 5hmC is severely affected but not completely abolished in zygotes lacking Dnmt3a, indicating a potential activity of another DNA methyltransferase. As Dnmt1 has been previously demonstrated to be present in both fully grown oocytes 20, 29 as well as in early mouse embryos 26, 30, 31 , we have assessed the potential contribution of maternal Dnmt1 for the accumulation of 5hmC using the oocyte-specific Dnmt1-KO (Dnmt1 2lox/2lox , Zp3-Cre) (ref. 32). Interestingly, the lack of maternal Dnmt1 also leads to significantly lower levels of paternal 5hmC following fertilization (Fig. 4d ). The reduced paternal 5hmC in Dnmt3a and Dnmt1 KO zygotes is observed despite the normal presence and localization of Tet3 protein in these zygotes ( Fig. 4e,f To further validate the presence of de novo activity in the ooplasm and the role of 5hmC in targeting newly deposited 5mC, we performed somatic cell nuclear transfer (SCNT) using wild-type (WT) and triple KO Dnmt3a −/− , Dnmt3b −/− , Dnmt1 −/− (TKO) embryonic stem cells 33 (ESCs) as donor cells (Fig. 5a ). As expected, the nuclei of TKO-ESCs are devoid of both 5mC and 5hmC ( Supplementary  Fig. 5c ). At 5 h post-activation, 5mC and 5hmC are detected in the WT-ESC pseudopronucleus whereas the fully decondensed TKO-ESC pseudopronucleus does not show an appreciable amount of DNA modifications (Fig. 5a ). However, at 14 h post-activation both the WT-ESC and the TKO-ESC pseudopronuclei exhibit comparable levels of 5mC and 5hmC (Fig. 5a ). The presence of both DNA modifications on the originally 5mC/5hmC-free DNA template further demonstrates the presence of previously unappreciated de novo DNA methylation activities in the ooplasm and that Tet3 targets the newly formed 5mC. Interestingly, pericentromeric heterochromatin in WT-ESC-and TKO-ESC-derived pseudopronuclei is enriched for 5mC but not for 5hmC ( Supplementary Fig. 5d ), replicating the pattern observed on the paternal genome in PN4 zygotes 34 ( Supplementary Fig. 5e ).
Our detailed investigation of DNA modification dynamics in the zygote has revealed that 5hmC accumulation follows, but is not concomitant with, the loss of 5mC in the early (PN2-3) paternal pronucleus ( Fig. 1 ). Furthermore, we have shown that the initial loss of paternal 5mC can be mechanistically uncoupled from 5hmC formation using a genetic loss-of-function model and small-molecule inhibitors of dioxygenases, providing mechanistic proof that these processes are independent (Figs 2 and 3 and Supplementary Figs 2b-d , 3c and 4d,e,i). In this context it should be noted that the methylation analysis of embryos depleted for Tet3 has been previously conducted on late-stage (PN5) zygotes, which has left the dynamics of the DNA demethylation process underappreciated 1,3,7 .
The exact mechanism by which DNA demethylation proceeds in the zygote remains the subject of an intense scientific debate, with both active and passive models proposed [1] [2] [3] [4] 15, 16, [35] [36] [37] . Our study shows that, quantitatively, most observed global DNA demethylation proceeds independently of replication ( Supplementary Fig. 4c ,g,h) confirming previous bisulphite sequencing data 5, 6, 13, 35 . Although we cannot rule out that a small proportion of loci lose their methylation through dilution 15, 16 , this pathway provides only a limited contribution to the global methylation changes in the zygote. Combined with our findings regarding the lack of a major role for Tet3-driven oxidation, our data advocate the existence of an alternative mechanism implicated in the loss of paternal 5mC in the early (PN2-PN3) zygotes. In this context we note that both control and DMOG-treated zygotes show normal enrichment of the chromatinbound XRCC1 DNA repair protein in the paternal pronucleus ( Supplementary Fig. 5f ), suggesting that the previously reported activation of the base excision DNA repair pathway 7, 18 during DNA demethylation in the mouse zygotes does not require Tet3-driven 5mC hydroxylation. In further support of this we observed incorporation of new isotope-labelled deoxycytidine (dC * ) in pre-replicating zygotes ( Supplementary Fig. 5g,h) .
Contrary to previous assumptions, we show that zygotes contain de novo DNA methyltransferase activities and both maternally inherited Dnmt1 and Dnmt3a are necessary for the accumulation of paternal 5hmC. Our findings thus support a model whereby Tet3driven hydroxylation is predominantly implicated in the protection of the newly acquired hypomethylated state from accumulating new DNA methylation. This is achieved through targeting of newly formed 5mC generated by zygotic Dnmt3a and Dnmt1 enzymes or also possibly through preventing Dnmt1-driven methylation maintenance at some regions (Fig. 5b) .
Cumulatively, our study explains the previously observed low locus-specific 5hmC levels 35 , the limited effect of Tet3-KO on zygotic DNA demethylation 15, 16 and only limited overlap between 5hmC localizations and regions undergoing DNA demethylation 35 . We show that epigenetic reprogramming in the early embryo is a complex process underpinned by a dynamic interplay between active DNA demethylation, de novo DNA methylation and Tet3-driven 5mC hydroxylation. Finally, although our study provides information regarding the global dynamics of DNA modifications during zygotic reprogramming, further studies will be necessary to unravel locusspecific modification changes and targeting of the key factors involved in this fascinating process.
METHODS

Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper 27. Kaneda Tet3 conditional knockout (KO) mice were generated using a two-step strategy described in Fig. 3a . The targeting construct, which generates a null allele, is composed of exon 8 (ENSMUSE00000238680), exon 9 (ENSMUSE00000238677) and a FRT -flanked neomycin cassette, flanked by two loxP sites. Following insertion the KO allele was rescued in heterozygous Tet3 −/WT by crossing with a transgenic mouse expressing Flp recombinase. Tet3-maternally deleted oocytes (Tet3 mat-) were obtained by crossing Gdf9-Cre Tet3 lox/lox males with Tet3 lox/lox females and by superovulation of 3-week-old Gdf9-Cre Tet3 lox/lox females.
All animal experiments were carried out under a UK Home Office Project Licence in a Home Office-designated facility.
In vitro fertilization of mouse oocytes. The procedure was carried out as previously described 39 . The sperm was isolated from dissected epididymis and capacitated for 1.5 h in HTF fertilization medium (Millipore) supplemented with 4 mg ml −1 bovine serum albumin (BSA, Sigma-Aldrich). Oocytes were collected 14 h post-HCG injection into the same medium.
Inhibition of Tet proteins was performed by supplementing the fertilization medium with 1 mM dimethyloxallyl glycine (DMOG, Sigma-Aldrich) or 1 mM deferoxamine (DFX, Sigma-Aldrich) diluted in aqueous buffer; the oocytes were incubated with the drug for at least 40 min before the addition of the sperm. For replication inhibition, 3 µg ml −1 aphidicolin (Sigma-Aldrich, dissolved in dimethylsulphoxide) was added to the fertilization medium. As a control, zygotes were incubated with the matching concentration of dimethylsulphoxide (0.1-0.3%). For the quantification of maintenance and de novo DNA methylation, oocytes were incubated for at least 40 min before fertilization with 7.5 mg l −1 unlabelled methionine (Fluka) or isotope-labelled ( 13 C, d 3 ) methionine (Sigma) and kept in this supplemented medium during IVF. De novo DNA methylation was monitored by adding 2 µg ml −1 aphidicolin to the HTF medium.
Incorporation of isotope-labelled dC (dC * ) was assessed by incubating oocytes and zygotes with 5 mM ( 13 C, 15 N) deoxycytidine (Silantes) added into the IVF medium.
For culture of preimplantation embryos, zygotes (incubated with DMOG for 8 h when indicated) were transferred into M16 or KSOM medium (without DMOG) and cultured until morula stage (embryonic day E2.5) or blastocyst stage (E3.5).
Immunofluorescence staining of zygotes. Zygotes collected from natural matings of outbred MF1 mice were cleaned from cumulus cells by 5 min incubation in M2 medium (Sigma-Aldrich) containing 4 mg ml −1 BSA supplemented with 300 µg ml −1 hyaluronidase, and fixed for 20 min by 4% paraformaldehyde (PFA) in PBS, followed by three 10 min washes in PBS, 1% BSA. Permeabilization was performed for 30 min at room temperature in PBS, 1% BSA, 0.5% Triton X-100. Zygotes were then incubated overnight in PBS, 1% BSA, 0.1% Triton X-100 containing the first antibody, washed three times for 10 min with PBS, 1% BSA, 0.1% Triton X-100 and incubated for 1 h in the dark with Alexa Fluor 405-, 488-or 568-conjugated IgG secondary antibody (dilution 1:300, Molecular Probes) in the same buffer. Zygotes were mounted with ProLong Gold mounting medium containing DAPI (Life Technologies) using imaging spacers and imaged as Z-series confocal (Z step size 0.5 µm) sections using a Leica TCS SP5 confocal microscope with a ×40 objective.
For Triton pre-extraction, zygotes were incubated in ice-cold permeabilization solution (50 mM NaCl, 3 mM MgCl 2 , 0.5% Triton X-100, 300 mM sucrose in 25 mM HEPES pH 7.4) for 10 min on ice. Zygotes were then washed three times with permeabilization solution without Triton X-100, fixed for 20 min using 4% PFA in PBS at room temperature and stained as described above. To prevent the zona pellucida from collapsing under osmotic stress on transfer to the mounting media, zygotes were equilibrated in PBS, 1% BSA with increasing concentrations of glycerol before mounting.
5mC and 5hmC staining of mouse zygotes. Staining of DNA modifications was carried out as described previously 18 with some modifications. Briefly, after 40 min incubation at room temperature in the permeabilization buffer (PBS, 1% BSA, 0.5% Triton X-100) zygotes were treated with 10 mg ml −1 RNase A (Roche) in PBS, BSA 1% for 1 h at 37 • C. DNA was subsequently denatured using HCl 4 N for 15 min at 37 • C. Zygotes were then washed in PBS, 1% BSA for 10 min, incubated in PBS, 1% BSA, 0.1% Triton X-100 for 30 min and incubated in the same buffer with 5mC and 5hmC antibody at 4 • C overnight. Zygotes were subsequently washed three times in PBS, 1% BSA, 0.1% Triton X-100 for 10 min and incubated with Alexa Fluor 405-, 488-or 568-conjugated IgG secondary antibodies (dilution 1:300, Molecular Probes) for 1 h at room temperature in the dark. DNA was stained by propidium iodide (PI; 0.25 mg ml −1 ) for 20 min. The final wash was carried out in PBS, 1% BSA for 30 min and the zygotes mounted in ProLong Gold DAPI-free mounting medium (Life Technologies) as described above.
Images were analysed using ImageJ software. The mid-section of each pronucleus was identified using PI staining and determined by the maximal area. The midsection was used to quantify the total intensity of each DNA modification following the subtraction of the signal corresponding to the equal cytoplasmic area (representing staining background). Within each experiment, zygotes were imaged using the same settings on the microscope (laser power and gain) to compare the signal intensity in both pronuclei. When using pat./mat. signal ratios, we carefully checked that the maternal intensity remained unchanged between the control and experimental conditions. Statistical analysis was carried out using two-tailed Student's t-test with Welch's correction when required, using GraphPad Prism software.
For 5mC/5hmC dynamics (Fig. 1) the staining was additionally carried out using a swapped combination of fluorophores and laser channels to control for technical biases. The 5mC/5hmC kinetics was also independently assessed using the same imaging channel for 5mC and 5hmC (using single-antibody staining of zygotes). In all cases, the results confirmed our findings presented in Fig. 1c .
Dnmt3b −/− DNMT -TKO, clone 19, obtained from RIKEN Bio Resource Center no. RBRC-AES0146 and described in ref. 33) were cultured in GMEM (Gibco), 15% FBS (Sigma), 0.1 mM non-essential amino acids (Gibco), 1 mM sodium pyruvate (Sigma), 2,000 U ml −1 ESGRO mouse LIF (Millipore), 0.1 mM 2-mercaptoethanol (Gibco) without feeders. Before electrofusion, cells were arrested at metaphase by incubation with 0.5 µg ml −1 nocodazole (Sigma-Aldrich) for 4 h. MII oocytes were incubated in HEPES-buffered CZB medium supplemented with 5 µg ml −1 cytochalasin B (Sigma-Aldrich) for 10 min at room temperature. Enucleation was performed as reported previously 41, 42 . Briefly, after 10 min treatment, MII oocytes were transferred into 10 µl of the same medium covered with mineral oil (Sigma-Aldrich) on the lid of a culture dish. All micromanipulations were performed under an inverted microscope equipped with Hoffman optics using a piezo-driven system (Prime Tech). After removal of metaphase chromosomes, a wild-type or DNMT -TKO ESC arrested at metaphase was introduced into the perivitelline space of the enucleated oocyte 43 . The fusion of the donor and recipient was induced by a d.c. pulse of 2,500 V cm −1 for 10 µs using an ECM 830 (BTX) in 300 mM mannitol, 0.1 mM MgSO 4 , 0.1 mg ml −1 polyvinyl alcohol and 3 mg ml −1 bovine serum albumin. The fusion rates were determined 1 h after the pulse by microscopic examination. Fused pairs were activated by treatment with 10 mM SrCl 2 in calcium-free CZB medium for 1 h. The reconstructed embryos were cultured in M16 medium (Millipore) in 5 % CO 2 in air at 37 • C.
Reverse transcription and quantitative PCR analysis.
Total RNA was purified using Trizol (Life Technologies) following the manufacturer's instructions. Randomprimed reverse transcription was performed using PrimeScript RT Reagent Kit with gDNA Eraser (Perfect Real Time, Takara Bio). cDNA corresponding to 1.5-3 zygotes in 3 µl was added to 10 µl of quantitative PCR mix containing SensiMix SYBR No-ROX (Bioline). Real-time quantitative PCR reactions were performed on a CFX96 real-time PCR detection system (Bio-Rad). The standard curve method using ESC cDNA was used for quantification. Primers: H3f3a_F 5 -CCATGCCAAACGTGTA ACAA-3 ; H3f3a_R 5 -TACCTTTGACCCCATGGAAA-3 ; Tet3 exon 3_F 5 -GCC TCCTTCCCTACTTCCAC-3 ; Tet3 exon 3_R 5 -CCTGGACCTGGATTTCTTGA-3 ; Tet3 exon 11_F 5 -TTGACTGGTCCCAGCCTAAC-3 ; Tet3 exon 11_R 5 -TGA AGGGATCCCACAGTTTC-3 . Two-tailed unpaired t-test was performed by using GraphPad Prism software.
Parthenogenetic activation of oocytes. MII oocytes were incubated with KSOM medium where Ca 2+ had been replaced with 10 mM strontium (Sigma) supplemented with 5 µg ml −1 cytochalasin B (Sigma) for 1.5 h. Parthenogenetically activated oocytes were then transferred into HTF medium supplemented with 2 µg ml −1 aphidicolin and 5 µg ml −1 cytochalasin B. Completion of S phase was monitored by incubating the parthenotes for 45 min in HTF medium supplemented with 400 µM EdU before staining as described below.
EdU staining in zygotes using Click-IT chemistry. To verify replication inhibition by aphidicolin and the completion of S phase in parthenogenetically activated oocytes, embryos were incubated with 400 µM of 5-ethynyl deoxyuridine (EdU, Life Technologies) during development before removal of the zona pellucida and fixation for 20 min in PFA 4% at room temperature. When indicated, a pulse of EdU was performed by incubating the zygotes for 30 min before zona pellucida removal and fixation.
EdU staining followed the manufacturer's instruction (Click-iT Nascent RNA capture kit, Life Technologies). Briefly, zygotes were permeabilized in PBS, 1% BSA, 0.5% Triton X-100 for 30 min at room temperature, washed twice in PBS, 1% BSA and incubated for 1 h in dark with a Click-IT reaction mix containing 2.5 µl of Alexa Fluor Azide 488. Zygotes were subsequently washed several times in PBS, 1% BSA and mounted in ProLong DAPI mounting medium.
DNA isolation from sperm, oocytes and early-stage embryos. Sperm DNA from B6CBAF1 was isolated using a protocol modified from ref. 44 . Fresh sperm from dissected epididymis was left to settle in HTF medium. Supernatant containing active sperm was centrifuged for 2 min at 1,100g and resuspended in 200 µl of solution A (75 mM NaCl and 25 mM EDTA) and 200 µl of solution B (10 mM Tris-HCl pH 8, 10 mM EDTA, 2% SDS, 80 mM dithiothreitol) complemented with 1 µg of RNAse A (Qiagen) and incubated for 1 h at 37 • C. One hundred micrograms of Proteinase K (Roche) per 0.5 ml of solution A+B was subsequently added and incubated overnight at 55 • C. Sperm genomic DNA was further purified using phenol/chloroform/isoamyl alcohol extraction followed by ethanol precipitation; DNA pellet was resuspended in LC-MS-quality-grade water (Fisher Scientific).
Genomic DNA from oocytes and two-cell embryos was isolated using a DNA Micro Kit (Qiagen) according to the manufacturer's instructions, without RNA carrier. DNA was eluted in LC-MS-quality-grade water (Fisher Scientific). For samples of zygotes (when indicated), both polar bodies were first carefully removed by micromanipulation (Narishige) before DNA extraction.
Liquid chromatography-mass spectrometry. Genomic DNA of 100 to 600 cells was used for quantification of DNA modifications. DNA was digested to nucleosides using 1 U of benzonase (Novagen), 0.5 mM phosphodiesterase I (Sigma) and 200 mU of alkaline phosphatase in 20 mM Tris-HCl pH 7.9, 4 mM MgCl 2 for a minimum of 6 h at 37 • C, or using a digestion enzymatic mix (NEB). Samples were precleaned by acetonitrile precipitation. All samples and standard curve points were spiked with isotope-labelled synthetic nucleosides (100 fmol of dC * and dG * , 5 fmol of 5mC * , 500 amol of 5hmC * ) obtained from T. Carell (Center for Integrated Protein Science at the Department of Chemistry, Ludwig-Maximilians-Universität München, München, Germany). The nucleosides were separated on an Agilent RRHD Eclipse Plus C18 2.1 × 100 mm 1.8u column by using the UHPLC 1290 system (Agilent) and analysed using an Agilent 6490 triple quadrupole mass spectrometer. To calculate the concentrations of individual nucleosides, standard curves representing the ratio of the peak response of known amounts of synthetic nucleosides spiked with the same matrix as the samples and the peak response of the isotope-labelled nucleosides were generated and used to convert the peak-area values to corresponding concentrations. Thresholds for quantification are: signal-to-noise (calculated with a peak-to-peak method) above 10 and the limit of quantification as detailed for each nucleoside in the Supplementary Fig. 4a . For non-quantifiable peaks (n.d.), an overestimation of the 5mC/dG or 5hmC/dG ratio is calculated based on the limit of detection for both nucleosides.
Reproducibility of experiments.
This journal's policy precludes the use of statistical analysis for data where n < 3 biological replicates. However, in our LC-MS experiments, we observed a very low variation between biological replicates with a coefficient of variation below 10 for 5mC (Figs 2b,c and 3e,f, and Supplementary  Fig. 4c,e,h) . Additionally, LC-MS results are technically supported by immunofluorescence data (Figs 2a and 3d and Supplementary Figs 2b and 4i ) and bisulphite sequencing analysis ( Supplementary Figs 3d-f and 4j) , and conceptually by alternative approaches (conditional KO mouse model and small-molecule inhibitors of dioxygenases). It should also be noted that each LC-MS measurement reflects DNA modification quantification of a pool of about 100 embryos, analysed in technical duplicates. LC-MS data (Fig. 2b , DNA modifications in zygotes without polar bodies) represent three biological replicates (except for the DMOG-treated data point); a replicate of this experiment (zygotes with polar bodies) is shown in Supplementary  Fig. 4e . LC-MS results presented in Figs 2c and 4a and Supplementary Figs 4c ,e,h and 5g are based on two biological replicates (each carried out in technical duplicates).
Immunofluorescence data presented in Fig. 2a and Supplementary Fig. 2b were reproduced four times independently, Figs 3d and 4c,d and Supplementary Figs 2f, 3c and 5b twice independently. It should be noted that for the quantification of DNA modifications in zygotes by immunofluorescence, each embryo represents a biological replicate.
Statistics derived from bisulphite sequencing analysis ( Supplementary Figs 3d-f  and 4j ) rely on the number of clones amplified; experiments presented in Supplementary Fig. 3d ,e were reproduced twice independently. Supplementary Figure 1 (c) 5fC and 5caC stainings in PN3 and PN4 zygotes. Note that in the early zygote 5fC (and 5caC) is observed in the maternal pronucleus only (see also Supplementary Fig. 2c,d Figure 1c ). (Scale bars, 5um.) (e) 5hmC staining in pre-implantation embryos derived from in vitro fertilisation in the presence of DMOG. 5hmC is not detectable at 2-cell stage following DMOG treatment which is in agreement with the absence of detectable Tet3 protein at this stage ( Supplementary Fig. 1a 
